Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Exp Eye Res. 2014 May 4;0:31–36. doi: 10.1016/j.exer.2014.04.020

Figure 5.

Figure 5

Indirect immunofluorescent confocal images of TSP-1 on full-thickness constructs at 4 weeks. A) Control, B) T1: TGF-β1 treated, and C) Rescue: TGF-β1 for 2 weeks then switched to TGF-β3 for 2 weeks. TSP-1 seemed unchanged between Control and T1 treated constructs; however, it was considerably downregulated with Rescue treatment. Blue = TOPRO3 nuclear counterstain, Bar = 50 microns.